Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders

THOMAS SENGHORE, YU-FENG LI, FUNG-CHANG SUNG, MING-HSUI TSAI, CHUN-HUNG HUA, CHIU-SHONG LIU, RU-JIUN HUANG and CHIH-CHING YEH
Anticancer Research August 2018, 38 (8) 4661-4666; DOI: https://doi.org/10.21873/anticanres.12771
THOMAS SENGHORE
1School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, R.O.C
2Department of Nursing, School of Medicine and Allied Health Sciences, University of The Gambia, Banjul, Gambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU-FENG LI
3Graduate Institute of Biostatistics, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUNG-CHANG SUNG
4Department of Health Services Administration, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MING-HSUI TSAI
5Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHUN-HUNG HUA
5Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIU-SHONG LIU
6Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RU-JIUN HUANG
1School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, R.O.C
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIH-CHING YEH
1School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, R.O.C
7Public Health, College of Public Health, China Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ccyeh@tmu.edu.tw
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: To investigate the effect of oxidative stress biomarkers on the risk of potentially malignant oral disorders (PMODs). Materials and Methods: A total of 208 male adults with PMODs and an equal number of same-age control patients were enrolled. Plasma biomarkers of oxidative stress, measured with 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-isoprostane (8-ISO), were determined using enzyme-linked immunosorbent assay kits. PMODs were diagnosed in accordance with the World Health Organization (WHO) guidelines. Results: A significant association between a high level of 8-ISO and an increased risk of PMODs was identified [odds ratio (OR)=1.71, 95% confidence interval (CI)=1.12-2.63; p=0.013]. This positive association was stronger among patients with PMOD subtype of leukoplakia (OR=1.94, 95% Cl=1.24-3.06; p=0.004). However, no significant association was observed between plasma 8-OHdG levels and overall risk of PMODs or subtypes. Conclusion: Our findings suggest that increased plasma 8-ISO levels may indicate the prominence of lipid peroxidation in the development of PMODs, particularly leukoplakia.

  • Potentially malignant oral disorders
  • leukoplakia
  • oxidative stress
  • biomarkers

Potentially malignant oral disorders (PMODs) pose a pressing public health challenge because of their high rate of transformation into oral malignancies. In Taiwan, oral cancer (OC) is a leading cause of mortality, especially among men aged 24 to 44 years (1), indicating the necessity of early intervention.

Tumor development is a complex process that is mediated by numerous endogenous and exogenous factors (2). Prominent among these is the induction of reactive oxygen species (ROS). At normal physiological concentrations, ROS act as signal molecules mediating cell growth, migration, and differentiation. High concentrations, however, induce cell death, apoptosis, and senescence (3), particularly when the antioxidant defense is overwhelmed. ROS can oxidize lipids and proteins and interact directly with DNA, thereby triggering oxidative stress (4, 5), which can lead to manifestation of 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-isoprostane (8-ISO) as biomarkers of oxidative damage (4, 6). Oxidative stress has been implicated in the pathogenesis of various pathologies, including oral tumors (7, 8).

The cytochrome P-450 (CYP-450) and glutathione S-transferase (GST) families of enzymes, which are involved in the metabolism and detoxification of toxic endogenous and environmental agents (9), play key roles in combating toxicity and ROS generation through their metabolites (10). We demonstrated in a previous study that genetic polymorphism in GSTM1 and CYP1A1*2C may increase susceptibility to PMODs, especially among smokers (11). Moreover, accumulated evidence has helped identify certain lifestyle factors, such as cigarette smoking, alcohol consumption, and betel-nut chewing, as risks for PMODs (12). Whether oxidative stress is associated with the risk of PMODs and whether such an association may be modified by genetic, environmental or lifestyle factors remains unclear.

Thus, the aim of this study was to investigate the association between oxidative stress biomarkers, measured based on 8-OHdG and 8-ISO levels, and the risk of PMODs. Additionally, we investigated how lifestyle factors and genetic polymorphisms affected the association between oxidative stress biomarkers and PMOD risk.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Comparison of characteristics of healthy controls and patients with potentially malignant oral disorders.

Materials and Methods

Participants. This case–control study included 208 male patients with PMODs and an equal number of control patients without oral lesions. A detailed description of participant characteristics has already been published (11). In brief, participants were recruited from a male penitentiary in Taiwan. A complete oral examination was conducted on all participants by two experienced otolaryngologists in accordance with World Health Organization guidelines (13). Patients with PMOD were those diagnosed with submucous fibrosis or leukoplakia, and controls of the same ages were randomly selected from individuals with healthy oral-screening results.

All eligible subjects completed a self-administered questionnaire covering information on sociodemographics, personal and family medical history, and lifestyle habits such as cigarette smoking, betel-nut chewing, and alcohol consumption. Based on their habits, participants were categorized as nonsmokers, current smokers (had been smoking for more than 1 year), or former smokers (had not smoked for at least the previous 6 months). Total cigarette consumption was computed in pack-years (PY), as the number of packs of cigarettes smoked daily multiplied by the duration of time (years) spent smoking. Body-mass index (BMI) was calculated from weight and height measurements as (weight/height2; kg/m2). The Ethics Review Committee of China Medical University and Hospital approved this study (IRB No: DMR96-IRB-085). All participants provided written, informed consent following a detailed explanation of the study objectives.

DNA isolation and genotyping. The methods for DNA isolation and genotyping were reported previously (11). In summary, 10 ml of venous blood was collected from all participants for genomic extraction. From buffy-coated cells, genomic DNA for genotyping was isolated. Genotyping of GSTM1, GSTT1, GSTP1, and CYP1A1*2C was performed through polymerase chain reaction/restriction fragment length polymorphism. A 10% random sample was retested and showed 100% concordance for all polymorphisms. All laboratory personnel were blinded to disease status of participants.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Associations between biomarkers of oxidative stress and risk of potentially malignant oral disorders.

Measurements of plasma 8-OHdG and 8-ISO. Measurements of 8-OHdG and 8-ISO in plasma samples were carried out using enzyme-linked immunosorbent assay kits (Cayman Chemical Company, Ann Arbor, MI, USA) by following the kit protocol. The intra- and inter-assay variability coefficients were 4.7%-11.6% and 4.5%-10.7%, respectively, for 8-OHdG, and 6.4%-12.6% and 10.5%-24.3%, respectively, for 8-ISO.

Statistical analysis. Data analysis was performed using the SAS Statistical Package (Vers. 9.4 for Windows; SAS Institute, Cary, NC, USA). Statistical differences between cases and controls were assessed using the Student's t-test, Pearson's chi-squared test, or the Kruskal–Wallis test, where appropriate. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to assess the association between oxidative stress biomarkers and risk of PMODs. Adjusted ORs were calculated using multivariate logistic regression models with adjustments for education, BMI, cigarette smoking (PY), alcohol consumption, and betel-nut chewing. Further analysis was conducted to examine the effects of lifestyle factor–biomarker and gene–biomarker interactions on the risk of PMODs. The levels of 8-OHdG and 8-ISO were dichotomized into binary variables according to median values for the controls. The joint effects of lifestyle factors (cigarette smoking, alcohol consumption, and betel-nut chewing), and genetic polymorphisms (GSTM1, GSTT1, GSTP1, and CYP1A1*2C) with biomarkers were also estimated using multivariate regression models with adjustments for covariates. Due to the high proportion of smokers in our sample, the median smoking time among controls (13 PY) was used to examine the interaction between biomarkers and smoking habit. Statistical significance was two-sided and set at p<0.05.

Results

Table I compares characteristics between cases and controls. The case group had higher mean BMI (p=0.038), a higher proportion of overweight subjects (p=0.019), a higher proportion of current and former betel-nut chewers (p=0.019), a lower median 8-OHdG level (p=0.053), and a higher median 8-ISO level (p=0.009) than did the control group.

No significant association was observed between 8-OHdG and overall risk of PMODs or leukoplakia in the multivariate logistic regression models. However, high levels of 8-OHdG were marginally significantly associated with lower risk of submucous fibrosis (p=0.063). Additionally, 8-ISO was significantly associated with an increased risk of PMODs (p=0.013) and leukoplakia (p=0.004) but not with an increased risk of submucous fibrosis (p=0.587) (Table II). Therefore, we further examined the joint effects of 8-ISO and lifestyle or genetic factors on the risk of PMODs.

Table III lists the effects of 8-ISO on the risk of PMODs and leukoplakia, as stratified according to lifestyle factors. No statistically significant interaction between 8-ISO and lifestyle factors was observed; however, 8-ISO elevation conferred an approximately two-fold or more increased risk of PMODs and leukoplakia in participants with ≤13 PY of smoking (p=0.018 and p=0.002, respectively) and in participants who ever consumed alcohol (p=0.046 and p=0.014, respectively). Moreover, 8-ISO elevation more than doubled the risk of leukoplakia alone in participants who had never been betel-nut chewers (p=0.027) and significantly increased risk in those who had been betel-nut chewers (p=0.046).

No significant interaction was observed between genetic polymorphisms and the oxidative stress biomarker on risks for PMODs or leukoplakia. After stratifying according to genotype, participants with GSTM1-null (p=0.038) or CYP1A1*2C AA (p=0.034) genotypes and high 8-ISO level exhibited a significantly increased risk of leukoplakia. Participants with GSTT1-null (p=0.005 and p=0.002) or GSTP1 AA (p=0.027 and p=0.015) genotypes and high 8-ISO level exhibited increased risk of both PMOD and leukoplakia (Table IV).

Discussion

PMODs carry a significant risk for malignant transformation (14). Among them, OC is highly prevalent in Taiwan (15). Evidence has linked oxidative DNA damage and lipid peroxidation to such malignancies, including OC (7, 16, 17). In this study, we demonstrated that a high 8-ISO level was significantly associated with an increased risk of PMODs, particularly leukoplakia. We also revealed that both genetics and lifestyle factors may modify the effects of these biomarkers on the risk of PMODs.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Association between 8-isoprostane (8-ISO) level and the risk of potentially malignant oral disorders, stratified according to lifestyle factors.

As a byproduct of oxidative DNA damage, 8-OHdG is considered a reliable biomarker of oxidative damage (18). Research evidence has established a correlation between 8-OHdG level and PMODs and OC (8). Conversely, our analysis revealed lower levels of 8-OHdG in patients with PMODs than in controls, indicating that a high 8-OHdG level conferred no risk of PMODs. In this study, we obtained measurements of plasma 8-OHdG levels, that may reflect both oxidative DNA damage and a deficient DNA-repair system. A defect in the repair of 8-OHdG residue may indicate that 8-OHdG levels are elevated in tissue and peripheral leukocytes, but low in plasma (19). Thus, our results may reflect a defective DNA-repair system in our case patients because plasma 8-OHdG is derived from residual repaired 8-OHdG in DNA. The 8-OHdG levels measured in plasma were also lower in patients with colon cancer than in control patients (20). Similarly, Rossner et al. determined there was no association between plasma 8-OHdG level and breast cancer (21).

ROS-induced lipid peroxidation has been shown to be mutagenic and may serve as a reliable biomarker of both cellular damage and DNA adducts (8). Therefore, we also assessed oxidative stress by examining plasma 8-ISO levels. Our data revealed that patients with high 8-ISO levels had increased susceptibility to PMODs and leukoplakia, which is consistent with the findings of other studies on patients with colon cancer, oesophageal cancer, and leukoplakia (17, 22, 23). The sensitivity of cell membranes to ROS induces lipid peroxidation that can produce a variety of mutagenic carbonyl products (24) and contribute to neoplastic transformation.

We further examined the combined effects of 8-ISO and lifestyle factors on the risk of PMODs and leukoplakia. No significant effects were observed, but individuals with a high 8-ISO level who fell in the category of either smokers of ≤13 PY or those who had ever consumed alcohol exhibited a significantly increased risk of both PMODs and leukoplakia. Alcohol consumption and smoking are established risk factors for PMODs (12). Interestingly, only those with high 8-ISO levels who had smoked for relatively few PY (≤13) exhibited an increased risk of PMODs and leukoplakia. This may be because the majority of our participants (96%) were cigarette smokers. When we stratified the results according to smoking status (never-smoked and ever-smoked), the results were significant for those who ever- smoked, but no results were generated for participants who had never smoked because of their small number. Since, we could not elucidate the effects of 8-ISO on PMODs in nonsmokers, further studies may be required. We observed that regardless of betel-nut chewing habit, 8-ISO only increased the overall risk of PMODs, which supports the conclusions of other reports regarding the independent effects of both 8-ISO and betel-nut chewing on leukoplakia (12, 17).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Association between 8-isoprostane (8-ISO) levels and risk of potentially malignant oral disorders, stratified according to genetic polymorphism.

Our data also demonstrated that polymorphisms of drug-metabolizing genes may modify the effects of 8-ISO on PMOD risk. Participants with high 8-ISO levels and GSTT1-null or GSTP1 AA genotypes exhibited increased risk of both PMODs and leukoplakia, whereas GSTM1-null and CYP1A1*2C AA genotypes exhibited an increased susceptibility to leukoplakia. These findings support those of other studies that both GST and CYP independently affect the development of PMODs and leukoplakia (25, 26). The adverse effects of ROS through lipid peroxidation have previously been linked to OC and leukoplakia development (17, 26). The development of PMODs involves multiple processes, including molecular and cellular processes, which lead to tumor formation. These processes are mediated by ROS (27), which have been determined to initiate and promote tumor formation (8). In the presence of low antioxidant levels, ROS also attack the polyunsaturated fatty acids of fatty-acid membranes, causing lipid peroxidation that eventually results in changes to cell-membrane structure and functionality. The polymorphisms of GSTM1, GSTT1, GSTP1, and CYP1A1*2C have been discovered to affect OC and PMODs (25). Various studies have also demonstrated the association of both GSTM1-null and CYP1A1*2C AA genotypes with increased risk of leukoplakia (11, 28).

Our study findings must be interpreted in light of several limitations. Firstly, we measured plasma 8-OHdG, which may reflect not only oxidative DNA stress but also DNA repair efficiency. SecondIy, we did not include nutritional and psychological factors, which may have some effects on oral tumors. Thus, the exclusion of these confounding factors in future studies may be required in order to determine the effects of oxidative stress on PMODs. Finally, our participants were males from a penitentiary and therefore might not be representative of the general Taiwanese population.

Conclusion

Our findings revealed that an elevated level of plasma 8-ISO, but not 8-OHdG in patients with PMOD compared to control patients might indicate the prominence of lipid peroxidation in the development of PMODs, particularly leukoplakia.

Acknowledgements

The Authors are grateful to study participants.

  • Received June 26, 2018.
  • Revision received July 11, 2018.
  • Accepted July 13, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Su C-C,
    2. Tsai K-Y,
    3. Hsu Y-Y,
    4. Lin Y-Y,
    5. Lian I-B
    : Chronic exposure to heavy metals and risk of oral cancer in Taiwanese males. Oral Oncol 46(8): 586-590, 2010.
    OpenUrlPubMed
  2. ↵
    1. Swenberg JA,
    2. Lu K,
    3. Moeller BC,
    4. Gao L,
    5. Upton PB,
    6. Nakamura J,
    7. Starr TB
    : Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology, and risk assessment. Toxicol Sci 120(Suppl 1): S130-S145, 2011.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Valko M,
    2. Rhodes CJ,
    3. Moncol J,
    4. Izakovic M,
    5. Mazur M
    : Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1): 1-40, 2006.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Marczynski B,
    2. Rozynek P,
    3. Kraus T,
    4. Schlosser S,
    5. Raithel HJ,
    6. Baur X
    : Levels of 8-hydroxy-2’-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat Res 468(2): 195-202, 2000.
    OpenUrlPubMed
  5. ↵
    1. Xing F,
    2. Li Z,
    3. Sun A,
    4. Xing D
    : Reactive oxygen species promote chloroplast dysfunction and salicylic acid accumulation in fumonisin B1-induced cell death. FEBS Lett 587(14): 2164-2172, 2013.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Thomson CA,
    2. Giuliano AR,
    3. Shaw JW,
    4. Rock CL,
    5. Ritenbaugh CK,
    6. Hakim IA,
    7. Hollenbach KA,
    8. Alberts DS,
    9. Pierce JP
    : Diet and biomarkers of oxidative damage in women previously treated for breast cancer. Nutr Cancer 51(2): 146-154, 2005.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Ma N,
    2. Tagawa T,
    3. Hiraku Y,
    4. Murata M,
    5. Ding X,
    6. Kawanishi S
    : 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 14(2): 137-143, 2006.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Choudhari SK,
    2. Chaudhary M,
    3. Gadbail AR,
    4. Sharma A,
    5. Tekade S
    : Oxidative and antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncol 50(1): 10-18, 2014.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Sheweita SA
    : Drug-metabolizing enzymes: Mechanisms and functions. Curr Drug Metab 1(2): 107-132, 2000.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sosa V,
    2. Moliné T,
    3. Somoza R,
    4. Paciucci R,
    5. Kondoh H,
    6. Lleonart ME
    : Oxidative stress and cancer: An overview. Ageing Res Rev 12(1): 376-390, 2013.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Li YF,
    2. Sung FC,
    3. Tsai MH,
    4. Hua CH,
    5. Liu CS,
    6. Huang YT,
    7. Yeh CC
    : Interactions between cigarette smoking and polymorphisms of xenobiotic-metabolizing genes: The risk of oral leukoplakia. Dis Markers 34(4): 247-255, 2013.
    OpenUrl
  12. ↵
    1. Kadashetti V,
    2. Shivakumar KM,
    3. Chaudhary M,
    4. Patil S,
    5. Gawande M,
    6. Hande A
    : Influence of risk factors on patients suffering from potentially malignant disorders and oral cancer: A case–control study. J Oral Maxillofac Pathol 21(3): 455-456, 2017.
    OpenUrl
  13. ↵
    1. Warnakulasuriya S,
    2. Johnson NW,
    3. van der Waal I
    : Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36(10): 575-580, 2007.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Speight PM,
    2. Khurram SA,
    3. Kujan O
    : Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol 125(6): 612-627, 2017.
    OpenUrl
  15. ↵
    1. Chiang C-J,
    2. Lo W-C,
    3. Yang Y-W,
    4. You S-L,
    5. Chen C-J,
    6. Lai M-S
    : Incidence and survival of adult cancer patients in Taiwan, 2002-2012. J Formos Med Assoc 115(12): 1076-1088, 2016.
    OpenUrl
  16. ↵
    1. Poulsen HE,
    2. Prieme H,
    3. Loft S
    : Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 7(1): 9-16, 1998.
    OpenUrlPubMed
  17. ↵
    1. Srivastava KC,
    2. Shrivastava D
    : Analysis of plasma lipid peroxidation and antioxidant enzymes status in patients of oral leukoplakia: A case–control study. J Int Soc Prev Community Dent 6(Suppl 3): S213-s218, 2016.
    OpenUrl
  18. ↵
    1. Ziech D,
    2. Franco R,
    3. Georgakilas AG,
    4. Georgakila S,
    5. Malamou-Mitsi V,
    6. Schoneveld O,
    7. Pappa A,
    8. Panayiotidis MI
    : The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188(2): 334-339, 2010.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Kondo S,
    2. Toyokuni S,
    3. Tanaka T,
    4. Hiai H,
    5. Onodera H,
    6. Kasai H,
    7. Imamura M
    : Overexpression of the hOGG1 gene and high 8-hydroxy-2’-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHdG level in DNA. Clin Cancer Res 6(4): 1394-1400, 2000.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Niedernhofer LJ,
    2. Daniels JS,
    3. Rouzer CA,
    4. Greene RE,
    5. Marnett LJ
    : Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278(33): 31426-31433, 2003.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Rossner P Jr..,
    2. Gammon MD,
    3. Terry MB,
    4. Agrawal M,
    5. Zhang FF,
    6. Teitelbaum SL,
    7. Eng SM,
    8. Gaudet MM,
    9. Neugut AI,
    10. Santella RM
    : Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(4): 639-644, 2006.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Brys M,
    2. Morel A,
    3. Forma E,
    4. Krzeslak A,
    5. Wilkosz J,
    6. Rozanski W,
    7. Olas B
    : Relationship of urinary isoprostanes to prostate cancer occurrence. Mol Cell Biochem 372(1-2): 149-153, 2013.
    OpenUrlPubMed
  23. ↵
    1. Freitas Bde J,
    2. Lloret GR,
    3. Visacri MB,
    4. Tuan BT,
    5. Amaral LS,
    6. Baldini D,
    7. de Sousa VM,
    8. de Castro LL,
    9. Aguiar JR,
    10. Pincinato Ede C,
    11. Mazzola PG,
    12. Moriel P
    : High 15-F2t-isoprostane levels in patients with a previous history of nonmelanoma skin cancer: The effects of supplementary antioxidant therapy. Biomed Res Int 2015: 963569, 2015.
    OpenUrl
  24. ↵
    1. Benamira M,
    2. Johnson K,
    3. Chaudhary A,
    4. Bruner K,
    5. Tibbetts C,
    6. Marnett LJ
    : Induction of mutations by replication of malondialdehyde modified M13 DNA in Escherichia coli: Determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced. Carcinogenesis 16(1): 93-99, 1995.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Liu H,
    2. Jia J,
    3. Mao X,
    4. Lin Z
    : Association of CYP1A1 and GSTM1 polymorphisms with oral cancer susceptibility: A meta-analysis. Medicine 94(27): e895, 2015.
    OpenUrl
  26. ↵
    1. Chole RH,
    2. Patil RN,
    3. Basak A,
    4. Palandurkar K,
    5. Bhowate R
    : Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther 6(4): 487-491, 2010.
    OpenUrlPubMed
  27. ↵
    1. Valko M,
    2. Jomova K,
    3. Rhodes CJ,
    4. Kuca K,
    5. Musilek K
    : Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol 90(1): 1-37, 2016.
    OpenUrlCrossRefPubMed
  28. ↵
    1. He P,
    2. Wei M,
    3. Wang Y,
    4. Liu Q
    : Associations among glutathione S-transferase T1, M1, and P1 polymorphisms and the risk of oral leukoplakia. Genet Test Mol Biomarkers 20(6): 312-321, 2016.
    OpenUrl
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (8)
Anticancer Research
Vol. 38, Issue 8
August 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders
THOMAS SENGHORE, YU-FENG LI, FUNG-CHANG SUNG, MING-HSUI TSAI, CHUN-HUNG HUA, CHIU-SHONG LIU, RU-JIUN HUANG, CHIH-CHING YEH
Anticancer Research Aug 2018, 38 (8) 4661-4666; DOI: 10.21873/anticanres.12771

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders
THOMAS SENGHORE, YU-FENG LI, FUNG-CHANG SUNG, MING-HSUI TSAI, CHUN-HUNG HUA, CHIU-SHONG LIU, RU-JIUN HUANG, CHIH-CHING YEH
Anticancer Research Aug 2018, 38 (8) 4661-4666; DOI: 10.21873/anticanres.12771
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Docosahexaenoic Acid Potentiates the Anticancer Effect of the Menadione/Ascorbate Redox Couple by Increasing Mitochondrial Superoxide and Accelerating ATP Depletion
  • Streptonigrin Mitigates Lung Cancer-induced Cachexia by Suppressing TCF4/TWIST1-induced PTHLH Expression
  • Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer
Show more Experimental Studies

Similar Articles

Keywords

  • potentially malignant oral disorders
  • leukoplakia
  • oxidative stress
  • biomarkers
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire